Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.94
1.86
NAV
₹37.40
₹37.96
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹2971.07 Cr
₹6658.41 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
1.81%
8.03%
3 Year
21.31%
27.09%
5 Year
14.44%
16.93%
Equity
97.91%
97.60%
Cash
2.09%
2.37%
Top 10 Holdings
Ipca Laboratories Ltd. | 8.40% |
Sun Pharmaceutical Industries Ltd. | 8.25% |
Cipla Ltd. | 8.08% |
Globus Medical Inc | 7.54% |
Illumina Inc. (USA) | 7.18% |
Laurus Labs Ltd. | 5.95% |
Gland Pharma Ltd. | 5.72% |
Sai Life Sciences Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.56% |
Cohance Lifesciences Ltd. | 3.81% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
